These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 699984)

  • 1. Affinities of drugs for the agonist and antagonist states of the dopamine receptor.
    Riddall DR; Leavens WJ
    Eur J Pharmacol; 1978 Sep; 51(2):187-8. PubMed ID: 699984
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine receptors in subcellular fractions from bovine caudate: enrichment of [3H]spiperone binding in a postsynaptic membrane fraction.
    Near JA; Mahler HR
    J Neurochem; 1981 Mar; 36(3):1142-51. PubMed ID: 7205263
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):52-6. PubMed ID: 7132962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations concerning the cellular origin of dopamine receptors.
    Henn FA; Titeler M; Anderson DJ; May K
    Life Sci; 1978 Aug; 23(6):617-21. PubMed ID: 692285
    [No Abstract]   [Full Text] [Related]  

  • 6. [3H]205-501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors.
    Closse A; Frick W; Markstein R; Maurer R; Nordmann R
    J Neural Transm; 1985; 62(3-4):231-48. PubMed ID: 3161996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3H-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptors.
    Creese I; Padgett L; Fazzini E; Lopez F
    Eur J Pharmacol; 1979 Jul; 56(4):411-2. PubMed ID: 477735
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple dopamine binding sites: subcellular localization and biochemical characterization.
    Clement-Cormier YC; George RJ
    J Neurochem; 1979 Mar; 32(3):1061-9. PubMed ID: 430039
    [No Abstract]   [Full Text] [Related]  

  • 9. Pseudo non-competitive agonist interactions with dopamine receptors.
    Sibley DR; Creese I
    Eur J Pharmacol; 1980 Jul; 65(1):131-3. PubMed ID: 7398773
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective labeling of apomorphine receptors by 3H-LSD.
    Whitaker PM; Seeman P
    Eur J Pharmacol; 1979 Jun; 56(3):269-71. PubMed ID: 225177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species variation in dopamine receptor binding.
    Creese I; Stewart K; Snyder SH
    Eur J Pharmacol; 1979 Nov; 60(1):55-66. PubMed ID: 520417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple receptors for brain dopamine.
    Titeler M; Weinreich P; Sinclair D; Seeman P
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1153-6. PubMed ID: 418405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptors in rat frontal cortex: pharmacological properties in vivo and in vitro.
    Bacopoulos NG; Ware PL
    Life Sci; 1980 Dec 22-29; 27(25-26):2489-94. PubMed ID: 6163938
    [No Abstract]   [Full Text] [Related]  

  • 14. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective labelling of different dopamine receptors by a new agonist 3H-ligand: 3H-N-propylnorapomorphine.
    Titeler M; Seeman P
    Eur J Pharmacol; 1979 Jun; 56(3):291-2. PubMed ID: 477726
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of soluble dopamine D2-receptors from three species.
    Madras BK; Davis A; Seeman P
    Eur J Pharmacol; 1982 Mar; 78(4):431-8. PubMed ID: 7075677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
    Titeler M
    Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
    [No Abstract]   [Full Text] [Related]  

  • 18. Partial purification of the D2 dopamine receptor from bovine caudate nucleus.
    Williamson RA; Worrall S; Chazot PL; Strange PG
    Biochem Soc Trans; 1988 Aug; 16(4):450-2. PubMed ID: 2974812
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiparkinsonian drug doses and neuroleptic receptors.
    Titeler M; Seeman P
    Experientia; 1978 Nov; 34(11):1490-2. PubMed ID: 720482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state.
    Sibley DR; Mahan LC; Creese I
    Mol Pharmacol; 1983 Mar; 23(2):295-302. PubMed ID: 6835198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.